Moreover, immune cytokines such as TNF-α, INF-α, and IL-10 in the tumor microenvironment are involved in the immune reaction; thus, we monitored a variety of these cytokines in neoadjuvant therapy, by which we established a predictive model to screen out patients who might benefit from the neoadjuvant immunotherapy–chemotherapy formula. Here, IL10 is linked to neoplasm.